Universita Degli Studi Di Verona

2 trials 2 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Countries active

9 Unique IMPs

N/A Results reported

Phase II

Phase IV

Phase II: 1 Phase IV: 1

Top IMPs

AMITRIPTYLINE HYDROCHLORIDE 1 CITALOPRAM HYDROCHLORIDE 1 ESCITALOPRAM OXALATE 1 FLUOXETINE HYDROCHLORIDE 1 OLAPARIB 1 PAROXETINE 1 SERTRALINE 1 VENLAFAXINE HYDROCHLORIDE 1 VORTIOXETINE 1

All trials

2 total

PASSION (olaParib mAintenance in chemotherapy-Sensitive metaStatic pancreatIc adenOcarciNoma - mPDAC): a phase II, proof of principle, study Recruiting

2025-522530-31-01 Phase II 1 country OLAPARIB
"SAFE DISCONTINUATION OF ANTIDEPRESSANTS IN INDIVIDUALS WITH CLINICALLY REMITTED DEPRESSIVE DISORDERS" Recruiting

2023-509377-23-00 Phase IV 1 country AMITRIPTYLINE HYDROCHLORIDE; CITALOPRAM HYDROCHLORIDE; ESCITALOPRAM OXALATE; FLU…

Showing 1–2 of 2 trials

← All sponsors A–Z